Powered by Smartsupp
Odyssey Therapeutics
Founded
2021
Status
Private
Leadership
Gary D. Glick, Ph.D - Founder, President, & CEO
LSVP Investment
2025
Stage Invested
Series D
Lightspeed Team
Dr. Shelley Chu - Partner
Jonathan MacQuitty - Partner
Dr. Brenton Fargnoli - Partner
Ravi Mhatre - Partner & Co-Founder
Odyssey is on a mission to transform the standard of care for patients affected by autoimmune and inflammatory conditions. We target upstream signaling nodes and mechanisms like those in the innate immune system to prevent pathological inflammation before it occurs.
Odyssey Therapeutics